High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trial
Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital), Kiyuk Chang(St. Mary's Hospital), Kyeong Ho Yun(Wonkwang University Hospital), Sungmin Lim(The University of Sydney), Gyu Chul Oh(The Catholic University of Korea Seoul St. Mary's Hospital), Yun‐Seok Choi(The Catholic University of Korea Yeouido St. Mary's Hospital), Ik Jun Choi(The Catholic University of Korea Incheon St. Mary's Hospital), Kwan Yong Lee(Catholic University of Korea), Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Han Cheol Lee(Pusan National University Hospital), O Sung Kwon(St. Mary's Hospital), Chul Soo Park(Gyeongsang National University), Tae Soo Kang(Dankook University), Chan Joon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Mahn‐Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Dong‐Bin Kim(St. Paul's Hospital), Hun Sik Park(Kyungpook National University Hospital), Sunam Lee(The Catholic University of Korea St. Vincent's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Joong Kyung Sung(Hung Vuong Hospital), Seong‐Ill Woo(Inha University)
Cited by 0
Related Papers
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
|Journal of the American College of Cardiology|2012|643
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
|JAMA|2015|603
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493